Cyclin L1 抗体
Quick Overview for Cyclin L1 抗体 (ABIN7464115)
抗原
See all Cyclin L1 (CCNL1) 抗体适用
宿主
克隆类型
标记
应用范围
-
-
交叉反应
- 人
-
纯化方法
- Purified by antigen-affinity chromatography.
-
免疫原
- Recombinant protein encompassing a sequence within the center region of human Cyclin L1. The exact sequence is proprietary.
-
亚型
- IgG
-
-
anti-Cyclin L1 (CCNL1) (C-Term) antibody
CCNL1 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (AA 1-172) antibodyCCNL1 适用: 人 WB, ELISA, IF 宿主: 小鼠 Monoclonal 1F7-1C5 unconjugated
anti-Cyclin L1 (CCNL1) (AA 314-369) antibodyCCNL1 适用: 人 WB, IHC, ELISA, IP 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (C-Term) antibodyCCNL1 适用: 人 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (C-Term) antibodyCCNL1 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (AA 32-81) antibodyCCNL1 适用: 人, 小鼠, 大鼠, Cow, Pig, 豚鼠, 非洲爪蟾, 猴 WB 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (C-Term) antibodyCCNL1 适用: 人, 小鼠, 大鼠, 犬, Cow, Pig WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Cyclin L1 (CCNL1) (AA 461-510) antibodyCCNL1 适用: 人, 小鼠, 大鼠 WB, IHC, ELISA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- WB: 1:500-1:3000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
说明
-
Positive Control: 293T , 293T nuclear extract
Validation: Orthogonal
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1.12 mg/mL
-
缓冲液
- 1XPBS ( pH 7), 20 % Glycerol, 0.025 % ProClin 300
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
储存方法
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- Cyclin L1 (CCNL1)
-
别名
- cyclin L1
-
背景
- Cyclin L1 , ANIA6A , BM-001 , PRO1073 , ania-6a,Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.
-
分子量
- 60 kDa
-
基因ID
- 57018
-
UniProt
- Q9UK58
抗原
-
